Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
The New England Journal of Medicine
|
May 9, 1974
In utero diagnosis of hemoglobinopathies. Hemoglobin synthesis in fetal red cells
H Chang, J C Hobbins, G Cividalli, et al.
Transplantation Proceedings
|
February 1, 1989
The use of total lymphoid irradiation (TLI) for prevention of rejection of T-lymphocyte depleted bone marrow allografts in non-malignant hematological disorders
S Slavin, E Naparstek, M Aker, et al.
Cancer
|
January 5, 2000
Effective preventive central nervous system therapy with extended triple intrathecal therapy and the modified ALL-BFM 86 chemotherapy program in an enlarged non-high risk group of children and adolescents with non-B-cell acute lymphoblastic leukemia: the Israel National Study report
B Stark, R Sharon, G Rechavi, et al.
Bone Marrow Transplantation
|
October 1, 1995
Cytosine arabinoside as a major risk factor for Streptococcus viridans septicemia following bone marrow transplantation: a 5-year prospective study
D Engelhard, H Elishoov, R Or, et al.
Lancet (London, England)
|
September 1, 1984
Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1)
H Waldmann, A Polliak, G Hale, et al.
Transplantation Proceedings
|
February 1, 1987
Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disorders
S Slavin, R Or, E Naparstek, et al.
British Journal of Haematology
|
March 1, 1995
T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapse
E Naparstek, R Or, A Nagler, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1985
Elimination of graft versus host disease in matched allogeneic leukemic transplant recipients using CAMPATH-1
S Slavin, R Or, L Weiss, et al.
Progress in Clinical and Biological Research
|
January 1, 1989
Bone marrow transplantation with T-cell depleted allografts for the treatment of severe beta thalassemia major
R Or, E Naparstek, M Aker, et al.
Experimental Hematology
|
July 2, 1999
Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies
E Naparstek, M Delukina, R Or, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
The New England Journal of Medicine
|
May 9, 1974
In utero diagnosis of hemoglobinopathies. Hemoglobin synthesis in fetal red cells
H Chang, J C Hobbins, G Cividalli, et al.
Transplantation Proceedings
|
February 1, 1989
The use of total lymphoid irradiation (TLI) for prevention of rejection of T-lymphocyte depleted bone marrow allografts in non-malignant hematological disorders
S Slavin, E Naparstek, M Aker, et al.
Cancer
|
January 5, 2000
Effective preventive central nervous system therapy with extended triple intrathecal therapy and the modified ALL-BFM 86 chemotherapy program in an enlarged non-high risk group of children and adolescents with non-B-cell acute lymphoblastic leukemia: the Israel National Study report
B Stark, R Sharon, G Rechavi, et al.
Bone Marrow Transplantation
|
October 1, 1995
Cytosine arabinoside as a major risk factor for Streptococcus viridans septicemia following bone marrow transplantation: a 5-year prospective study
D Engelhard, H Elishoov, R Or, et al.
Lancet (London, England)
|
September 1, 1984
Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1)
H Waldmann, A Polliak, G Hale, et al.
Transplantation Proceedings
|
February 1, 1987
Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disorders
S Slavin, R Or, E Naparstek, et al.
British Journal of Haematology
|
March 1, 1995
T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapse
E Naparstek, R Or, A Nagler, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1985
Elimination of graft versus host disease in matched allogeneic leukemic transplant recipients using CAMPATH-1
S Slavin, R Or, L Weiss, et al.
Progress in Clinical and Biological Research
|
January 1, 1989
Bone marrow transplantation with T-cell depleted allografts for the treatment of severe beta thalassemia major
R Or, E Naparstek, M Aker, et al.
Experimental Hematology
|
July 2, 1999
Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies
E Naparstek, M Delukina, R Or, et al.
Page
of 7